# Topical anesthesia
Topical anesthesia is the production of surface numbness by applying a local anesthetic drug to intact skin or a mucous membrane, so that minor procedures such as venipuncture, [laceration repair](https://www.edgepedia.org/laceration-repair), and mucosal instrumentation can be done without needles or with less pain. Applied drugs diffuse to nerve endings in the epidermis, dermis, or superficial mucosa and reversibly block pain signals; the numbing they produce is superficial, and its depth and duration depend on the formulation, the site, and the application time.
| Key fact | Detail |
|---|---|
| Depth on intact skin | EMLA gives about 3 mm of analgesia after 60 minutes and about 5 mm after 120 minutes, measured by needle insertion [1](https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941S11LBL.PDF) |
| Onset on skin | 30 to 60 minutes for most creams; tetracaine creams work within 30 to 45 minutes, EMLA after at least 60 minutes [2](https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2023.1350578/full) • [3](https://adc.bmj.com/content/archdischild/early/2025/02/10/archdischild-2024-326917.full.pdf) |
| Onset on mucosa | Genital mucosa 5 to 10 minutes; mucosal tetracaine acts in 2 minutes with 20 minutes to 1 hour of effect [4](https://www.medicines.org.uk/emc/product/871/smpc) • [5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) |
| EMLA composition | A eutectic 1:1 mixture of 2.5% w/w lidocaine (25 mg/g) and 2.5% w/w prilocaine (25 mg/g), about 80% active substance in the oil phase versus about 20% in older formulations [6](https://doi.org/10.1111/j.1399-6576.1982.tb01822.x) |
| Dose ceiling (lidocaine) | Keep total topical lidocaine below 300 mg and at or below 4.5 mg/kg body weight in healthy adults [7](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c48cfac-81eb-4a81-8590-bc94574dd4c3) |
| Principal toxicity | Methemoglobinemia, chiefly with benzocaine and prilocaine-containing products [5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) |
## How it works
Local anesthetics reversibly block sodium channels within nerve fibers, preventing depolarization and therefore transmission of pain signals.[8](https://www.uptodate.com/contents/clinical-use-of-topical-anesthetics-in-children) The target fibers lie in the epidermis and dermis, shielded by the stratum corneum, a highly lipophilic, water-impermeable barrier.[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC12166667/) Topical formulations overcome this barrier by passive diffusion from creams or gels, or by needle-free methods such as pressurized gas delivery, heat-enhanced diffusion, and iontophoresis.[8](https://www.uptodate.com/contents/clinical-use-of-topical-anesthetics-in-children) Mucosal absorption is more rapid than across intact skin, with onset on genital mucosa in 5 to 10 minutes, so mucosal onset is measured in minutes while intact skin requires close to an hour.[4](https://www.medicines.org.uk/emc/product/871/smpc) Topical products are more concentrated than injectable anesthetics to drive diffusion, and vasoconstrictors are generally omitted for mucosal use because they undermine that permeability.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/)
The eutectic principle explains EMLA. Mixing lidocaine and prilocaine liquids lowers the melting point of the mixture to 18 °C, allowing a high anesthetic concentration in the cream's oil phase rather than the roughly 20% of a single drug dissolved in a cream base; the finished cream contains 2.5% of each drug.[6](https://doi.org/10.1111/j.1399-6576.1982.tb01822.x) • [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC4676230/) Liposomal formulations encapsulate lidocaine in phospholipid vesicles, protecting the molecule and slowing its metabolism, which extends the effect; the heated lidocaine/tetracaine patch warms the skin to 39 to 41 °C to enhance absorption and vasodilation.[2](https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2023.1350578/full) • [11](https://link.springer.com/article/10.1007/s00431-026-06826-5)
## How it is done
For intact skin, the cream is applied in a thick layer under an occlusive dressing. The EMLA label specifies 2.5 g over 20 to 25 cm² (or one 1 g disc over 10 cm²) for at least 1 hour for minor procedures such as venipuncture, and 2 g per 10 cm² for at least 2 hours for major procedures such as split skin graft harvesting.[1](https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941S11LBL.PDF) [Satisfactory](https://www.edgepedia.org/satisfactory) dermal analgesia is achieved at 1 hour, reaches a maximum at 2 to 3 hours, and persists 1 to 2 hours after removal.[1](https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941S11LBL.PDF) Depth increases with time, from about 3 mm at 60 minutes to about 5 mm at 120 minutes.[1](https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941S11LBL.PDF) Some sites need less time: facial skin is maximal at 30 to 60 minutes and male genital skin at 15 minutes.[4](https://www.medicines.org.uk/emc/product/871/smpc) Pediatric dosing is capped by age and weight according to the product label.[12](https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019941s021lbl.pdf)
On genital mucosa no occlusive dressing is needed, and analgesia after 5 to 10 minutes lasts about 15 to 20 minutes.[4](https://www.medicines.org.uk/emc/product/871/smpc) For mucosal tetracaine, onset is 2 minutes with 20 minutes to 1 hour of duration, and doses should be limited to 20 mg (1 mL of 2% solution) per session even in healthy adults because respiratory mucosa absorbs it quickly.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) For wound repair, LET gel (4% lidocaine, 0.05% epinephrine, 0.5% tetracaine) is applied directly into the laceration before suturing, typically for about 20 to 30 minutes.[13](https://pmc.ncbi.nlm.nih.gov/articles/PMC9746881/)
## Origin
Cocaine supplied the first topical anesthetic. Pure cocaine has a local anesthetic property and can produce surgical local anesthesia and nerve block.[14](https://www.woodlibrary-museum.org/wp-content/uploads/e-books/wlmrep_14_14pdf.pdf) • [15](https://brieflands.com/journals/aapm/articles/17291.pdf) The search for less toxic agents that followed Niemann's finding that cocaine is an ester of benzoic acid produced a progression of synthetic local anesthetics, culminating in lidocaine, synthesized by Nils Löfgren in 1943.[16](https://www.ovid.com/jnls/ejanaesthesiology/fulltext/10.1097/eja.0000000000000168~from-cocaine-to-lidocaine-great-progress-with-a-tragic)
Modern topical anesthesia of intact skin dates to the eutectic mixture. A 1982 paper by Ehrenström Reiz and Reiz in Acta Anaesthesiologica Scandinavica reported EMLA, a eutectic mixture of prilocaine and lidocaine, and showed in 60 children aged 6 to 15 years that it significantly reduced venous cannulation pain compared with placebo (\( p < 0.001 \)) with negligible local side effects.[6](https://doi.org/10.1111/j.1399-6576.1982.tb01822.x) Later comparative studies shaped the current formulary: Browne and colleagues reported in 1999 in the Canadian Journal of Anesthesia that topical amethocaine (Ametop) was superior to EMLA for intravenous cannulation [17](https://doi.org/10.1007/bf03013194); Eichenfield and colleagues evaluated 4% liposomal lidocaine (ELA-Max) against EMLA for pediatric venipuncture in PEDIATRICS in 2002 [18](https://doi.org/10.1542/peds.109.6.1093); Ernst and colleagues compared LET gel with TAC gel for scalp and facial lacerations in children in PEDIATRICS in 1995 [19](https://doi.org/10.1542/peds.95.2.255); and Sawyer and colleagues compared the heated lidocaine/tetracaine patch (Synera, Rapydan) with EMLA before vascular access in the British Journal of Anaesthesia in 2009.[20](https://doi.org/10.1093/bja/aen364)
## Variants
**EMLA** is a 5% oil-in-water emulsion cream (25 mg/g of lidocaine and 25 mg/g of prilocaine, pH 9.4) also available as a patch with 25 mg of each drug.[10](https://pmc.ncbi.nlm.nih.gov/articles/PMC4676230/) • [3](https://adc.bmj.com/content/archdischild/early/2025/02/10/archdischild-2024-326917.full.pdf) **Tetracaine creams** (Ametop, 4% tetracaine HCl) are ester anesthetics whose lipophilicity gives faster skin penetration and an onset of about 30 minutes.[2](https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2023.1350578/full) **Liposomal lidocaine** (Maxilene, ELA-Max) reaches an effect in about 30 minutes, is available in the United States, and offers a more rapid-onset, less expensive alternative to EMLA.[2](https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2023.1350578/full) • [21](https://www.em-consulte.com/article/422609/article/topical-anesthetics-for-dermal-instrumentation-a-s) **Heated lidocaine/tetracaine patches** (Synera, Rapydan; 70 mg of each drug) use Controlled Heat-Assisted Drug Delivery, giving onset within 30 minutes and about 120 minutes of duration.[11](https://link.springer.com/article/10.1007/s00431-026-06826-5) The **S-Caine patch** uses the same eutectic 70 mg/70 mg lidocaine/tetracaine mixture with heat-assisted delivery.[11](https://link.springer.com/article/10.1007/s00431-026-06826-5) **LET** replaced **TAC** (tetracaine, adrenaline, cocaine) for lacerations: TAC carries greater expense, restricted-narcotic status, and toxicity potential, including a reported fatality from misuse and recurrent seizures after mucosal application.[22](https://pmc.ncbi.nlm.nih.gov/articles/PMC2277899/) **Benzocaine 20%** acts within 30 seconds and lasts about 5 to 15 minutes but is hardly effective on firm, densely innervated palatal mucosa.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) Formulations have evolved from cocaine solution through creams, ointments, gels, and liposomal preparations to patches and peels.[23](https://pmc.ncbi.nlm.nih.gov/articles/PMC1661648/)
## Applications
For needle procedures, EMLA has efficacy data in more than 2,300 pediatric patients for venipuncture, cannulation, vaccinations, and lumbar puncture.[4](https://www.medicines.org.uk/emc/product/871/smpc) A 2025 pediatric practice guideline based on 1,808 children recommends EMLA for minor needle-related procedures with a minimum application of 60 minutes, and suggests tetracaine creams when cannulation or puncture is needed within 30 to 60 minutes.[3](https://adc.bmj.com/content/archdischild/early/2025/02/10/archdischild-2024-326917.full.pdf) A 2024 meta-analysis found amethocaine gel surpassed EMLA in child-reported absence of pain and first-attempt cannulation success.[24](https://www.nature.com/articles/s41390-024-03113-7)
For lacerations, LET is the topical anesthetic of choice for simple facial and scalp lacerations in children [22](https://pmc.ncbi.nlm.nih.gov/articles/PMC2277899/); a meta-analysis found LET significantly reduced pain versus control while EMLA's pain reduction versus control was not significant.[13](https://pmc.ncbi.nlm.nih.gov/articles/PMC9746881/) In dentistry, EMLA reduces pain during probing, scaling, rubber-dam clamp placement, and palatine nerve block.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) Against injection, EMLA was comparable to subcutaneous lidocaine, less efficacious than intradermal lidocaine, and preferred by most patients [1](https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941S11LBL.PDF); topical agents also avoid the tissue distortion that infiltration causes.[8](https://www.uptodate.com/contents/clinical-use-of-topical-anesthetics-in-children)
## Limitations and alternatives
The main failure modes follow from the barrier. Intact stratum corneum limits penetration, so insufficient application time produces inadequate anesthesia; the 2025 guideline's 60-minute minimum for EMLA reflects this.[3](https://adc.bmj.com/content/archdischild/early/2025/02/10/archdischild-2024-326917.full.pdf) Mucosal anesthesia is superficial only, blocking pain in the superficial layer of the mucosa.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) Conversely, abraded skin or injured mucous membranes absorb drug readily, and because topical anesthetics are generally vasodilators, blood levels can quickly approach those of intravenous administration.[25](https://www.aapd.org/globalassets/media/publications/archives/klein-05-02.pdf) Ointment, gel, and spray formats also make the delivered dose hard to quantify.[25](https://www.aapd.org/globalassets/media/publications/archives/klein-05-02.pdf)
Methemoglobinemia is the characteristic systemic risk. Benzocaine is a well-documented cause, with repeated FDA warnings of severe or fatal outcomes, and it is prohibited in patients with a history of methemoglobinemia and in children under two years.[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/) EMLA and prilocaine are also associated with it [5](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/); in infants, peak methemoglobin concentrations occur about 8 hours after application and normalize after about 12 to 13 hours at recommended doses.[4](https://www.medicines.org.uk/emc/product/871/smpc) Per current US labeling, EMLA is contraindicated in patients with known hypersensitivity to amide-type local anesthetics; use in infants is restricted only in neonates before 37 weeks' gestation and in infants under 12 months receiving methemoglobin-inducing agents, with permitted doses of 1 g over 10 cm² for 1 hour (0 up to 3 months or < 5 kg) and 2 g over 20 cm² for 4 hours (3 up to 12 months and > 5 kg) [26](https://pdf.hres.ca/dpd_pm/00040608.PDF), and risk is elevated with G6PD deficiency, cardiac or pulmonary compromise, and infants under 6 months.[7](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c48cfac-81eb-4a81-8590-bc94574dd4c3) For lidocaine, toxicity with central nervous system symptoms and cardiac depression usually occurs above 5 mg/L in adults, but infants may develop CNS effects at 1 mg/L because of immature metabolism.[11](https://link.springer.com/article/10.1007/s00431-026-06826-5)
Compared with infiltration and nerve blocks, topical anesthesia is shallower and slower but needle-free and free of tissue distortion, which matters most in children, where it can reduce the need for physical and chemical restraint.[8](https://www.uptodate.com/contents/clinical-use-of-topical-anesthetics-in-children) For adults and older children with localized lesions, a thin layer of EMLA over the minimal necessary area should be left in place for about 60 minutes to achieve satisfactory dermal analgesia on intact skin; shorter application times require evidence for the particular formulation and clinical setting.[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC12970946/)
## References
1. [EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) FDA label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941S11LBL.PDF)
2. [Topical anesthetics for needle-related pain in adults and children (TOPIC): a mini-review](https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2023.1350578/full)
3. [Topical analgesia during needle-related procedures in children: a clinical practice guideline](https://adc.bmj.com/content/archdischild/early/2025/02/10/archdischild-2024-326917.full.pdf)
4. [EMLA Cream 5%, Summary of Product Characteristics (emc)](https://www.medicines.org.uk/emc/product/871/smpc)
5. [Recent advances in topical anesthesia](https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/)
6. [G. M. E. EhrenströmReizR.N.A., S. L. A. Reiz (1982). EMLA ‐ a Eutectic Mixture of Local Anaesthetics for Topical Anaesthesia. Acta Anaesthesiologica Scandinavica.](https://doi.org/10.1111/j.1399-6576.1982.tb01822.x)
7. [DailyMed – Lidocaine Hydrochloride Topical Solution 4%](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c48cfac-81eb-4a81-8590-bc94574dd4c3)
8. [Clinical use of topical anesthetics in children, UpToDate](https://www.uptodate.com/contents/clinical-use-of-topical-anesthetics-in-children)
9. [Systemic Risks of Topical Anesthetics in Barrier-Compromised Dermatologic Patients](https://pmc.ncbi.nlm.nih.gov/articles/PMC12166667/)
10. [Topical anesthesia (review)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4676230/)
11. [The use of the S-Caine patch is safe and feasible in children younger than three: a nonrandomised clinical trial](https://link.springer.com/article/10.1007/s00431-026-06826-5)
12. [EMLA Cream FDA label (2018)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019941s021lbl.pdf)
13. [Efficacy of EMLA and LET for Topical Use in Wound Management for Children: A Systematic Review and Meta-Analysis](https://pmc.ncbi.nlm.nih.gov/articles/PMC9746881/)
14. [The History of Anesthesiology (Wood Library-Museum)](https://www.woodlibrary-museum.org/wp-content/uploads/e-books/wlmrep_14_14pdf.pdf)
15. [Cocaine: What is the Crack? A Brief History of the Use of Cocaine as an Anesthetic](https://brieflands.com/journals/aapm/articles/17291.pdf)
16. [From cocaine to lidocaine (European Journal of Anaesthesiology)](https://www.ovid.com/jnls/ejanaesthesiology/fulltext/10.1097/eja.0000000000000168~from-cocaine-to-lidocaine-great-progress-with-a-tragic)
17. [John Browne and colleagues (1999). Topical amethocaine (Ametop™) is superior to EMLA for intravenous cannulation. Canadian Journal of Anesthesia/Journal canadien d anesthésie.](https://doi.org/10.1007/bf03013194)
18. [Lawrence F. Eichenfield and colleagues (2002). A Clinical Study to Evaluate the Efficacy of ELA-Max (4% Liposomal Lidocaine) as Compared With Eutectic Mixture of Local Anesthetics Cream for Pain Reduction of Venipuncture in Children. PEDIATRICS.](https://doi.org/10.1542/peds.109.6.1093)
19. [Amy A Ernst and colleagues (1995). Lidocaine Adrenaline Tetracaine Gel Versus Tetracaine Adrenaline Cocaine Gel for Topical Anesthesia in Linear Scalp and Facial Lacerations in Children Aged 5 to 17 Years. PEDIATRICS.](https://doi.org/10.1542/peds.95.2.255)
20. [J. Sawyer and colleagues (2009). Heated lidocaine/tetracaine patch (Synera™, Rapydan™) compared with lidocaine/prilocaine cream (EMLA®) for topical anaesthesia before vascular access. British Journal of Anaesthesia.](https://doi.org/10.1093/bja/aen364)
21. [Topical Anesthetics for Dermal Instrumentation: A Systematic Review of Randomized, Controlled Trials](https://www.em-consulte.com/article/422609/article/topical-anesthetics-for-dermal-instrumentation-a-s)
22. [Topical anesthesia (Keyes, Tallon, Rizos; Canadian Family Physician 1998)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2277899/)
23. [Percutaneous dermal drug delivery for local pain control](https://pmc.ncbi.nlm.nih.gov/articles/PMC1661648/)
24. [Eutectic mixture of local anesthetics and amethocaine as topical anesthetics in pediatrics: a meta-analysis](https://www.nature.com/articles/s41390-024-03113-7)
25. [Acute toxic methemoglobinemia caused by a topical anesthetic](https://www.aapd.org/globalassets/media/publications/archives/klein-05-02.pdf)
26. [EMLA Product Monograph (Canada)](https://pdf.hres.ca/dpd_pm/00040608.PDF)
27. [Risk-Stratified Use of Topical and Infiltrative Local Anesthetics in High-Risk Dermatologic Surgery](https://pmc.ncbi.nlm.nih.gov/articles/PMC12970946/)
---
*Topic: Encyclopedia › Life and health › Human health and medicine › Clinical assessment and procedures › Anesthesiology and perioperative care*
*Initially written Sep 29, 2026 · Reviewed: Sep 30, 2026 · Edited: Sep 30, 2026 · Last review: Sep 30, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license